<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Prevnar Vaccine: Nearly Half a Billion In Sales Last Year</title><link>http://articles.mercola.com/sites/articles/archive/2001/03/17/prevnar-part-two.aspx</link><description>By Tim O'Reiley Prevnar broke into the quiet world of vaccines last year with the amps cranked up. Introduced in February, American Home Products Corp.'s vaccine against pneumococcal bacteria, which can cause brain damage or death in young children in</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>